arXiv subjects

Simon Mathis

Publications and source records attributed to Simon Mathis.

8 recordsLinked to original sources

arXiv2026

Latent-Y: A Lab-Validated Autonomous Agent for De Novo Drug Design

Drug discovery relies on iterative expert workflows that are slow to parallelize and difficult to scale. Here we introduce Latent-Y, an AI agent that autonomously executes complete antibody design campaigns from text prompts, covering literature review, target analysis, epitope identification, candidate design, computational validation, and selection of lab-ready sequences. Latent-Y is integrated into the Latent Labs Platform, where it operates in the same environment as drug-discovery experts with access to bioinformatics tools, biological databases, and scientific literature. The agent can run fully autonomously end-to-end, or collaboratively, where researchers review progress, provide feedback, and direct subsequent steps. Candidate antibodies are generated using Latent-X2, our frontier generative model for drug-like antibody design. We demonstrate the agent's capability across three distinct campaign types: epitope discovery guided by therapeutic specifications, cross-species binder design, and autonomous design from a scientific publication targeting human transferrin receptor for blood-brain barrier crossing. Across nine targets, Latent-Y produced lab-confirmed nanobody binders against six, achieving a 67% target-level success rate with binding affinities reaching the single-digit nanomolar range, without human filtering or intervention. In user studies, experts working with Latent-Y completed design campaigns 56 times faster than independent expert time estimates, compressing weeks of work into hours. Because Latent-X2 is a general-purpose atomic-level model for biologics design, the same agent architecture naturally extends to macrocyclic peptide and mini-binder design campaigns, broadening autonomous discovery across therapeutic modalities. Latent-Y is available to selected partners at https://platform.latentlabs.com.

q-bio.BM↗

arXiv2025

Drug-like antibodies with low immunogenicity in human panels designed with Latent-X2

Drug discovery has long sought computational systems capable of designing drug-like molecules directly: developable and non-immunogenic from the start. Here we introduce Latent-X2, a frontier generative model that achieves this goal through zero-shot design of antibodies with strong binding affinities, drug-like properties, and, for the first time for any de novo generated antibody, confirmed low immunogenicity in human donor panels. Latent-X2 is an all-atom model conditioned on target structure, epitope specification, and optional antibody framework, jointly generating sequences and structures while modelling the bound complex. Testing only 4 to 24 designs per target in each modality, we successfully generated VHH and scFv antibodies against 9 of 18 evaluated targets, achieving a 50% target-level success rate with picomolar to nanomolar binding affinities. Designed molecules exhibit developability profiles that match or exceed those of approved antibody therapeutics, including expression yield, aggregation propensity, polyreactivity, hydrophobicity, and thermal stability, without optimization, filtering, or selection. In the first immunogenicity assessment of any AI-generated antibody, representative de novo VHH binders targeting TNFL9 exhibit both potent target engagement and low immunogenicity across T-cell proliferation and cytokine release assays. The model generalizes beyond antibodies: against K-Ras, long considered undruggable, we generated macrocyclic peptide binders competitive with trillion-scale mRNA display screens. These properties emerge directly from the model, demonstrating the therapeutic viability of zero-shot molecular design, now available without AI infrastructure or coding expertise at https://platform.latentlabs.com.

q-bio.BM↗

arXiv2025

Flows, straight but not so fast: Exploring the design space of Rectified Flows in Protein Design

Generative modeling techniques such as Diffusion and Flow Matching have achieved significant successes in generating designable and diverse protein backbones. However, many current models are computationally expensive, requiring hundreds or even thousands of function evaluations (NFEs) to yield samples of acceptable quality, which can become a bottleneck in practical design campaigns that often generate $10^4\ -\ 10^6$ designs per target. In image generation, Rectified Flows (ReFlow) can significantly reduce the required NFEs for a given target quality, but their application in protein backbone generation has been less studied. We apply ReFlow to improve the low NFE performance of pretrained SE(3) flow matching models for protein backbone generation and systematically study ReFlow design choices in the context of protein generation in data curation, training and inference time settings. In particular, we (1) show that ReFlow in the protein domain is particularly sensitive to the choice of coupling generation and annealing, (2) demonstrate how useful design choices for ReFlow in the image domain do not directly translate to better performance on proteins, and (3) make improvements to ReFlow methodology for proteins.

q-bio.BM↗

arXiv2025

Latent-X: An Atom-level Frontier Model for De Novo Protein Binder Design

Traditional drug discovery relies on rounds of screening millions of candidate molecules with low success rates, making drug discovery time and resource intensive. To overcome this screening bottleneck, we introduce Latent-X, an all-atom protein design model that enables a new paradigm of precision AI design. Given a target protein epitope, Latent-X jointly generates the all atom structure and sequence of the protein binder and target, directly modelling the non-covalent interactions essential for specific binding. We demonstrate its efficacy across two therapeutically relevant modalities through extensive wet lab experiments, testing as few as 30-100 designs per target. For macrocyclic peptides, Latent-X achieves experimental hit rates exceeding 90% on all evaluated benchmark targets. For mini-binders, it consistently produces potent candidates against all evaluated benchmark targets, with binding affinities reaching the low nanomolar and picomolar range - comparable to those of approved therapeutics - whilst also being highly specific in mammalian display. In direct comparisons with the state-of-the-art models AlphaProteo, RFdiffusion and RFpeptides under identical conditions demonstrates, Latent-X generates binders with higher hit rates and better binding affinities, and uniquely creates structurally diverse binders, including complex beta-sheet folds. Its end-to-end process is an order of magnitude faster than existing multi-step computational pipelines. By drastically improving the efficiency and success rate of de novo design, Latent-X represents a significant advance towards push-button biologics discovery and a valuable tool for protein engineers. Latent-X is available at https://platform.latentlabs.com, enabling users to reliably generate de novo binders without AI infrastructure or coding.

q-bio.BM↗

arXiv2024

DEFT: Efficient Fine-Tuning of Diffusion Models by Learning the Generalised $h$-transform

Generative modelling paradigms based on denoising diffusion processes have emerged as a leading candidate for conditional sampling in inverse problems. In many real-world applications, we often have access to large, expensively trained unconditional diffusion models, which we aim to exploit for improving conditional sampling. Most recent approaches are motivated heuristically and lack a unifying framework, obscuring connections between them. Further, they often suffer from issues such as being very sensitive to hyperparameters, being expensive to train or needing access to weights hidden behind a closed API. In this work, we unify conditional training and sampling using the mathematically well-understood Doob's h-transform. This new perspective allows us to unify many existing methods under a common umbrella. Under this framework, we propose DEFT (Doob's h-transform Efficient FineTuning), a new approach for conditional generation that simply fine-tunes a very small network to quickly learn the conditional $h$-transform, while keeping the larger unconditional network unchanged. DEFT is much faster than existing baselines while achieving state-of-the-art performance across a variety of linear and non-linear benchmarks. On image reconstruction tasks, we achieve speedups of up to 1.6$\times$, while having the best perceptual quality on natural images and reconstruction performance on medical images. Further, we also provide initial experiments on protein motif scaffolding and outperform reconstruction guidance methods.

cs.LG↗

arXiv2023

Predicting protein variants with equivariant graph neural networks

Pre-trained models have been successful in many protein engineering tasks. Most notably, sequence-based models have achieved state-of-the-art performance on protein fitness prediction while structure-based models have been used experimentally to develop proteins with enhanced functions. However, there is a research gap in comparing structure- and sequence-based methods for predicting protein variants that are better than the wildtype protein. This paper aims to address this gap by conducting a comparative study between the abilities of equivariant graph neural networks (EGNNs) and sequence-based approaches to identify promising amino-acid mutations. The results show that our proposed structural approach achieves a competitive performance to sequence-based methods while being trained on significantly fewer molecules. Additionally, we find that combining assay labelled data with structure pre-trained models yields similar trends as with sequence pre-trained models. Our code and trained models can be found at: https://github.com/semiluna/partIII-amino-acid-prediction.

cs.LG↗

arXiv2022

Thought experiments in a quantum computer

We introduce a software package that allows users to design and run simulations of thought experiments in quantum theory. In particular, it covers cases where several reasoning agents are modelled as quantum systems, such as Wigner's friend experiment. Users can customize the protocol of the experiment, the inner workings of agents (including a quantum circuit that models their reasoning process), the abstract logical system used (which may or not allow agents to combine premises and make inferences about each other's reasoning), and the interpretation of quantum theory used by different agents. Our open-source software is written in a quantum programming language, ProjectQ, and runs on classical or quantum hardware. As an example, we model the Frauchiger-Renner extended Wigner's friend thought experiment, where agents are allowed to measure each other's physical memories, and make inferences about each other's reasoning.

quant-ph↗

arXiv2022

Energy self-sufficient systems for monitoring sewer networks

Underground infrastructure networks form the backbone of vital supply and disposal systems. However, they are under-monitored in comparison to their value. This is due, in large part, to the lack of energy supply for monitoring and data transmission. In this paper, we investigate a novel, energy harvesting system used to power underground sewer infrastructure monitoring networks. The system collects the required energy from ambient sources, such as temperature differences or residual light in sewer networks. A prototype was developed that could use either a thermoelectric generator (TEG) or a solar cell to capture the energy needed to acquire and transmit ultrasonic water level data via LoRaWAN. Real-world field trials were satisfactory and showed the potential power output, as well as, possibilities to improve the system. Using an extrapolation model, we proved that the developed solution could work reliably throughout the year.

eess.SY↗